scholarly article | Q13442814 |
P50 | author | Matthias Habjan | Q46151229 |
Clas Ahlm | Q56945869 | ||
Maria Baudin | Q60449515 | ||
Christopher T Öberg | Q64682157 | ||
P2093 | author name string | Friedemann Weber | |
Magnus Evander | |||
Jonas Eriksson | |||
Anna K Överby | |||
Md Koushikul Islam | |||
P2860 | cites work | Reverse genetics systems as tools for the development of novel therapies against filoviruses | Q38244444 |
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase | Q39195523 | ||
T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus | Q39946457 | ||
Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein | Q40149516 | ||
MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening | Q40983664 | ||
Bright far-red fluorescent protein for whole-body imaging. | Q50681538 | ||
High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses | Q21144476 | ||
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays | Q28145712 | ||
Ribavirin--current status of a broad spectrum antiviral agent | Q28190105 | ||
Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cells | Q28482396 | ||
Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development | Q28486013 | ||
Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model | Q28539632 | ||
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation | Q33406230 | ||
Risk factors for severe Rift Valley fever infection in Kenya, 2007. | Q34034024 | ||
Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles | Q34055431 | ||
Hemorrhagic fever viruses as biological weapons: medical and public health management | Q34126496 | ||
MScreen: an integrated compound management and high-throughput screening data storage and analysis system. | Q34307121 | ||
Favipiravir (T-705), a novel viral RNA polymerase inhibitor | Q34374652 | ||
A systematic review of Rift Valley Fever epidemiology 1931-2014. | Q34487937 | ||
Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes | Q35097798 | ||
High-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses | Q35363438 | ||
NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis | Q36315241 | ||
Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis | Q36397378 | ||
Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay | Q36462318 | ||
Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals | Q36484009 | ||
Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research. | Q36683930 | ||
Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment | Q37683496 | ||
P433 | issue | 4 | |
P921 | main subject | Rift Valley fever virus | Q14276794 |
Rift Valley fever | Q326638 | ||
Rift Valley fever phlebovirus | Q24809101 | ||
P304 | page(s) | 354-362 | |
P577 | publication date | 2016-01-13 | |
P1433 | published in | Journal of Biomolecular Screening | Q6294856 |
P1476 | title | High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection | |
P478 | volume | 21 |
Q27468917 | A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection |
Q47547438 | Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound. |
Q47279983 | Identification of Inhibitory Compounds Against Singapore Grouper Iridovirus Infection by Cell Viability-Based Screening Assay and Droplet Digital PCR. |
Q26748980 | Making Bunyaviruses Talk: Interrogation Tactics to Identify Host Factors Required for Infection |
Q45324172 | Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection. |
Q97519293 | eIF2B as a Target for Viral Evasion of PKR-Mediated Translation Inhibition |
Search more.